Information Provided By: 
Fly News Breaks for January 3, 2017
ABCO
Jan 3, 2017 | 19:50 EDT
Piper Jaffray analyst Sean Wieland believes The Advisory Board's lowered outlook tonight should not come as a surprise to investors. The reduced outlook reflects the exiting of less profitable healthcare products as well as pressure on contract renewal driven by post-election uncertainty, Wieland tells investors in a research note. He views Advisory Board's restructuring as in line with the way the company has always operated. The analyst reiterates an Overweight rating on the shares with a $47 price target.
News For ABCO From the Last 2 Days
There are no results for your query ABCO
